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Abstract: This concept paper reviews issues pertaining to parasitic and vector-borne infections, of
humans, animals, or both, of topical relevance to the African continent as well as to neighbouring
and interconnected geographies. This analysis is carried out through the “One Health” lens, being
mindful of the central role of agriculture and livestock keeping in Africa’s sustainable development.
The possible agricultural transformation that the continent may undergo to fulfil the rising demand
for animal protein of its growing population, coupled with the ongoing climate changes, may
lead to potentially enhanced interactions among humans, domesticated and wild animals, in a
fast-changing environment. In this view, tackling parasitic conditions of livestock can prove being
multidimensionally beneficial by improving animal health as well as communities’ food security,
livelihood and public health. Accordingly, the value of applying the One Health approach to drug
discovery and development in the fight against parasitic neglected tropical diseases and zoonoses, is
also underscored. Overall, this article upholds the adoption of a holistic, global, interdisciplinary,
multisectoral, harmonised and forward-looking outlook, encompassing both life and social sciences,
when dealing with parasitic conditions of humans and animals, in Africa and beyond, in COVID-19
times and further.
Keywords: Africa; One Health; zoonoses; parasitology; vector-borne diseases; vectors; international
cooperation; research & innovation; education
1. Introduction
1.1. Africa, Present and Future
With nearly 60% of its population (~800 million) under the age of 25 years, Africa is
the “youngest” continent on earth [1]. Currently hosting a total of 1.37 billion people [2],
corresponding to almost a double of Europe’s 750 million, the continent is expected to
reach the size of 2.5 billion inhabitants by 2050 and of approximately 4 billion by 2100 [3].
By then, one person in every three worldwide will be from the African continent. This
exponential growth is expected to be accompanied by an equally significant increase in the
continent’s need in animal source foods. Indeed, Africa’s demand for meat, milk and eggs
will almost quadruple by 2050 [4,5], with annual growth rates of consumption estimated
at 2.3% for milk and 2.8% for meat (with beef and poultry being Africa’s most consumed
meats) [6]. Currently, however, not only Africa is overall a net food importer [7,8], but it is
also the most food insecure region in the world, the only one in which the absolute number
of undernourished people has increased in the past 30 years (282 million in 2020) [9,10],
and where that of stunted children under five is still rising (61.4 million in 2020) [10,11].
Presently, nearly 60% of Africans (798.8 million) are moderately or severely food insecure,
with more than 90% (724.4 million) of them residing in sub-Saharan Africa [10]. At the
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same time, overweight rates are also increasing [12], highlighting the continent’s need for
nutritious foods.
Yet, Africa harbours 60% of the world’s uncultivated arable land (~600 million
hectares) [8,13,14], with one-quarter of the world’s cultivable land being in sub-Saharan
Africa but only producing 10% of the global agricultural output [15]. Therefore, the conti-
nent’s rising demand for animal protein could be potentially met, at least partly, through
enhanced local agricultural production, made possible by improving the productivity of
farming processes (e.g., through land and water use optimisation and through the devel-
opment of local transformative value chains) [8,13], as envisaged by the African Union’s
Comprehensive Africa Agriculture Development Programme (CAADP) [16] and New
Alliance for food security and nutrition [17]. This agricultural transformation process
may also include possible access by livestock keepers to wild areas hardly attended or
inhabited thus far, to make room for livestock rearing and grazing [18]. By creating new
human–animal–environment interfaces, such an expansion may however bring health
risks, as pathogens from wildlife could spill over onto domestic animals and people [18].
Moreover, the ongoing climatic changes and global warming may also compound this
scenario. Indeed, the spread of desertification threatening several African regions such as
the Sahel and the Horn of Africa [19], may cause the potential concentration of livestock
keeping in certain areas, in the form of more intensified (than presently) livestock rearing,
conceivably increasing land erosion [13,20]. Furthermore, Africa’s ongoing vertiginous
urbanisation at a 3.5% yearly rate [21] is also expected to contribute to the convergence
of livestock and people on urban and peri-urban areas in the coming decades [22]. This
would provide intensified occasions of contact between humans, domesticated and wild
animals, thereby creating augmented opportunities for the emergence and transmission
of infectious diseases and zoonoses1 [22–24]. Altogether, this will require an enhanced
surveillance and monitoring of livestock and environmental health, including wildlife
movement and fitness, biodiversity richness, as well as use and management of water, land
cover and vegetation.
1.2. COVID-19, Agriculture and Livestock Keeping
Although with a certain degree of variability according to countries, overall Africa
has so far been hit by a lower number of COVID-19 cases and fatalities compared to
other continents of the world [25–27]. However, the pandemic has still shown to be a
major source of hindrance, especially during the first wave of lockdowns in 2020, when
the setbacks of international trade caused serious disruptions in food value chains and
supplies [28,29]. Under COVID-19, Africa’s food security has also been further weakened
due to income reductions and food price inflation, outcomes of lower availability of
agricultural labour and produces, reduced liquidity for traders and interruptions of social
protection programmes [30,31]. In 2020, the number of Africans facing hunger increased by
3%, with approximately 46 million more undernourished people being recorded compared
to the previous year [10]. In Nigeria, the biggest African economy by nominal GDP [32], for
instance, 75.5% of the adult population became moderately or severely food insecure (from
48.5% in 2018–2019) and 33.5% severely food insecure (from 14% in 2018–2019). Urban
households were significantly more food insecure, suggesting their higher vulnerability
compared to rural areas, following the onset of the pandemic [33]. This further highlights
the fragility of the African net food importing model.
Against this background, the role of agricultural development will be absolutely cru-
cial for Africa to rebound. Agriculture, including also livestock keeping, is indeed still the
largest economic sector in the continent, accounting on average for 15% of Africa’s GDP,
ranging from below 3% in Botswana and South Africa to over 50% in Chad [31,34]. Agricul-
ture employs 60% of Africa’s working age population [8], with at least 50% of the workforce
being represented by women [35]. Indeed, despite the intense ongoing urbanisation, a
significant proportion of Africa’s population (e.g., 60% in sub-Saharan Africa and 40% in
Northern Africa) still resides in rural areas [36], and oftentimes migrations to the cities
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are followed by returns to the country, according to a “circular” pattern [37]. Within this
context, family-owned smallholder farms account for approximately 80% (i.e., 33 million)
of all farms in Africa [38] and contribute up to 70% of the continent’s food supply [14]. The
term of “smallholder” farms, usually interchanged with “small-scale agriculture”, “family
farms”, “subsistence farms”, “resource-poor farm”, “low-income farms”, “low-input farm”
or “low-technology farm” [39,40], refers to contexts “operating under structural constraints
such as access to sub-optimal amounts of resources (e.g., capital and assets), technology
and markets” [40,41], and “in less than 2 hectares of cropland” [42]. Although on the rise
in some countries, medium-scale commercial farms (5–100 hectares), or “agribusiness”,
still represent an overall minority in the continent’ agricultural landscape [43,44].
Livestock keeping is an essential component of Africa’s agriculture, with 66% of
Africa’s land being used to graze animals [45]. The majority (i.e., over two-thirds) of
Africa’s smallholder farmers engage in livestock keeping (i.e., 44% in Nigeria up to 79%
in Niger), not only for sustenance, but also for livelihood, manure and traction [6]. In
addition to sedentary mixed crop-livestock farming, pastoralism is a key feature of the
continent’s livestock keeping, including 38 million herders [46,47] and representing the
main livelihood of an estimated 268 million people [48]. Practised in 43% of Africa’s land
mass, it is the dominant livelihoods system in drylands, from the Sahel to the Horn of
Africa, spanning also parts of Southern Africa [48]. Contributing 10–44% of GDP of African
economies, pastoralism displays the unique ability to add value and convert scarce natural
resources into animal source food and income, providing approximately 90% of the meat
consumed in East Africa and nearly 60% of the meat and milk products consumed in
West Africa [49]. The mobile transhumant or nomadic lifestyle, which is the essence of
pastoralism, often entailing cross-border movements, frequently exposes pastoralists to
social conflicts and violence, insecure land rights and access, vulnerability to climate change
and deteriorating natural resources as well as infectious and zoonotic diseases [46,47,50,51].
As a result, 13.4 million pastoralists in sub-Saharan Africa live in conditions of extreme
poverty [47,50]. Poor livestock keepers are indeed particularly exposed to zoonoses due
to their recurrent contacts with livestock, their consumption of often poorly processed
animal produces and their limited access to health provision, both for themselves and their
animals [50]. Furthermore, the majority of animal food sources and livestock in Africa
are traded in traditional and wet markets, which play a key role in Africa’s societies and
agricultural landscapes, not only as a source of nourishment and income, but also for social
and cultural cohesion [6,52]. With their number expected to grow to meet the increasing
demand of foodstuffs, accrued efforts will be needed to ensure food and livestock markets
in Africa will fulfil safety and quality standards in the interest of consumers and global
public health [52].
All in all, the ongoing steep demographic growth, coupled with the COVID-19 crisis
showing the unsustainability of Africa’s net food importing model, will likely require,
as a response, the enhancement of agricultural and livestock keeping activities in the
continent [30]. Indeed, investments in smallholder agriculture in Africa can lead to mul-
tidimensional benefits such as increasing food production and food security, poverty
reduction [14] and employment opportunities for Africa’s burgeoning working age popu-
lation, allowing the continent to harness its demographic dividend2 [53]. In sub-Saharan
Africa only, economic growth from agriculture is indeed estimated to be 11 times more
effective at reducing extreme poverty than any other sector [14].
Already intimate in the essence of smallholder farming, the human–animal bond and
interaction will still be at the centre and may be further enhanced in the years to come, as it
will play a critical role in securing Africa’s sustainable development. This will render the
need for surveilling and monitoring zoonotic infections ever topical in the continent, and
across all neighbouring, trading and partner geographies.
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2. One Health and Parasitic and Arthropod-Borne Infections
In a world dominated by the COVID-19 pandemic, the wording of “One Health” is
now widely known and employed, even beyond the scientific community. One Health
is defined, according to the Tripartite collaboration between the Food and Agriculture
Organization of the United Nations (FAO), the World Organisation for Animal Health
(OIE) and the World Health Organization (WHO), as “a collaborative, multidisciplinary,
and multisectoral approach that can address urgent, ongoing, or potential health threats
at the human–animal–environment interface at subnational, national, global and regional
levels” [54]. This stems from the realisation that (i) the health of human beings and animals
are interdependent on each other and on the health of the ecosystems they inhabit and that
(ii) approximately 60% of human infections and 75% of newly emerging infections originate
from an animal source [55]. The global recognition of the importance of this approach in
also reflected in the G20 Rome Declaration from the recent Global Health Summit, held in
May 2021 [56].
The locution of One Health is undoubtedly not novel to parasitologists, who, by
vocation, study infections and their causative agents and hosts, at the interface with human
and veterinary medicine. With special regards to parasitic conditions, Africa harbours
a plethora of them that require to be addressed according to the One Health approach,
due to the dependence of parasites and their potential vectors or intermediate hosts on
numerous environmental factors (e.g., availability and type of hosts (e.g., humans, domes-
ticated or wild animals), habitat conditions such as temperature, humidity, availability and
type of waters (e.g., running or stagnant ones), etc.). For instance, malaria, the parasitic
disease par excellence of the African continent, provides a (hopefully) compelling example
of a condition that needs to be tackled through One Health efforts, due to the zoophilic
behaviour of several competent mosquito vectors [57,58]. This is the approach taken by
recent investigations aiming at treating cattle and other livestock with ivermectin or macro-
cyclic lactone-based “endectocides”4 in order to reduce the fitness of competent malaria
vectors feeding on them [59]. Similarly, the application of pyrethroid-based insecticides
(e.g., deltamethrin, permethrin and lambdacyhalothrin) or arthropocides to cattle not only
aims to control livestock-specific ectoparasites but also to reduce populations of zoophilic
mosquitoes responsible for malaria transmission [57,60]. These methods could be consid-
ered as complementary tools that could help reduce malaria incidence in a given area,
although alone they may not suffice to eradicate the disease. It is nonetheless essential that
control campaigns consider all hosts on which competent mosquitoes feed and the outdoor
component of malaria transmission.
Other major parasitoses of the African continent are ascribed in the group of the
so-called Neglected Tropical Diseases (NTDs), of which Africa bears ~40% of the world’s
burden [61]. These are typical diseases of poverty, highly endemic in rural areas, not
coincidentally where hygiene conditions and water sanitation are poor and where tight
cohabitation between humans and animals occur [61]. Out of the 20 NTDs recognised
by the WHO, 19 occur in Africa, with 11 (nearly 60%) of them being of parasitological
aetiology. Of these, at least seven include zoonotic agents (see also Table 1). Although
not involving a parasitic causative agent, NTDs like dengue and chikungunya still require
parasitic arthropods (i.e., mosquitoes of the genus Aedes spp.) as vectors [62,63], further
highlighting the relevance of parasitological and entomological expertise in the study,
management and control of most NTDs in Africa and elsewhere (Table 1).
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Table 1. NTDs known to occur in Africa, with emphasis on those that are of parasitic aetiology and/or arthropod-borne
and/or of zoonotic importance. (Cells are coloured in grey every time the criteria from the respective columns are not met
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Guinea worm disease
















(Hansen disease) Mycobacterium leprae







(River blindness) Onchocerca volvulus X X
Rabies Rabies virus (RV) X
























Cysticercus cellulosae X X
Blinding trachoma Chlamydiatrachomatis
Endemic treponematoses (yaws) Treponemaspp.
Undoubtedly noteworthy in the area of One Health are also the so-called Neglected
Zoonotic Diseases (NZDs) [64], that are deemed as “neglected” due to under-reporting
on their occurrence, leading to an underestimation of their relevance to policy-makers
and donors [65]. The NZDs comprise a subgroup of NTDs (i.e., echinococcosis, foodborne
trematodiases, human African trypanosomiasis, leishmaniasis, rabies, schistosomiasis and
taeniasis/cysticercosis,), all of which except rabies are of parasitic aetiology. Currently,
rabies, echinococcosis, foodborne trematodiases and taeniasis/cysticercosis are considered
as priority NZDs by the WHO Department of Control of NTDs [64]; the fact that three of
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them are parasitic infections further highlights the topicality and heavy burden of parasites
in the realm of zoonoses. In addition, zoonotic causes of non-malarial febrile illnesses such
as anthrax, brucellosis and leptospirosis are also recognised by the WHO to be of growing
importance and are therefore monitored accordingly [64].
The control of NTDs is a firm component of the UN 2030 Agenda for Sustainable
Development, as reflected in its Sustainable Development Goal (SDG) target 3.3 aiming, by
2030, to “end the epidemics of AIDS, tuberculosis, malaria and NTDs ( . . . )” [66]. In the
past decade, some substantial progress was made in these regards, with 31 countries having
succeeded in eliminating at least one NTD, eight of them being in Africa [67]. However,
despite these results, many of the targets set by the WHO in the 2020 roadmap were not met,
in Africa and other endemic regions [61]. In particular, the overall control of NTDs was neg-
atively affected by the disruptions caused by the COVID-19 pandemic in the year 2020, with
major hindrances being recorded in the delivery of health services [68]. Accordingly, a new
NTD roadmap was defined for the period 2021–2030, identifying critical gaps and actions
required in order to prevent, control, eliminate or eradicate the 20 target diseases and dis-
ease groups [61]. Importantly, the new agenda fully acknowledges the value of adopting an
integrated One Health strategy for NTDs, promoting stronger multisectoral collaborations
among agriculture, livestock, wildlife, environment, food safety, health and other min-
istries [61]. Such a strategic development derives from the consideration that all zoonotic
NTDs, in order to be fully controlled in human populations, need to be managed appro-
priately and possibly synergistically in animal hosts and/or reservoirs. Notably, tackling
NTDs involving livestock species in their epidemiology (e.g., parasitoses like echinococ-
cosis, human African trypanosomiasis, schistosomiasis and taeniasis/cysticercosis), can
provide dual benefits in terms of human and economic development, by reducing risks of
zoonotic infections, on one hand, and improving communities’ livelihood, through better
animal health and productivity, on the other [65,69].
Moreover, the African continent is also affected by a number of vector-borne zoonotic
infections caused either by viruses (e.g., Crimean-Congo Haemorragic Fever (CCHF),
Rift Valley Fever (RVF) and Yellow Fever) [70–72] or by bacteria (e.g., relapsing fever
borrelioses, several rickettsioses (e.g., by Rickettsia aeschlimannii, Rickettsia africae, Rickettsia
conorii, Rickettsia felis, Rickettsia massiliae, Candidatus Rickettsia asemboensis, etc.) [73–76],
which require parasitological and entomological expertise to be effectively addressed, due
to their vectoral components (e.g., ticks in the case of CCHF, relapsing fever borreliosis and
rickettsioses; mosquitoes in the case of RVF; fleas in the case of R. felis and C. Rickettsia
asemboensis). Indeed, recognising the parasitological/entomological constituents in the
epidemiology of these infections is essential as it helps identifying potential arthropod or
vertebrate reservoirs, thus ultimately preventing and controlling the diseases in humans
and animals. In Uganda, for example, when it was first encountered, in 2013, CCHF
was initially feared to be the more deadly Ebola [77], which has occasionally crossed the
country’s border with the Democratic Republic of the Congo [78,79]. Ever since, CCHF
has occurred in the country in the form of outbreaks within or in the proximity of the
“cattle corridor”, a region spanning northeastern, central and southwestern districts, known
indeed for the density of its cattle herds [80,81]. With most cases being associated with
exposure to bites of ticks (especially Hyalomma spp.) who have fed on viraemic cattle or
ruminant hosts [80], the effective control of this infection could be achieved through the roll-
out of strategic targeted tick control programmes and the sensitisation of the general public
and farming communities on the epidemiology of CCHF. This would require a concerted
initiative to be conceived and implemented by several Ministries in coordination (e.g., in
the case of Uganda, a partnership between the Ministry of Health and the Ministry of
Agriculture, Animal Industry and Fisheries) [80]. Considering that the same cattle corridor
witnesses sporadic cases of mosquito-borne RVF [81], whose reservoir is also represented
by ruminants [71], One Health efforts in this area should opt for the use of “arthropocidal”
molecules, halting both ticks and mosquitoes, rather than merely “acaricidal” products
(controlling ticks) or “insecticidal” ones (controlling insects such as mosquitoes).
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Moreover, the role of “companion” animals or non-livestock species, such as dogs and
cats, is also critical for certain parasitic zoonoses in Africa. In addition to their involvement
in a number of NTDs (e.g., dogs as final hosts of Echinococcus granulosus and Dracunculus
medinensis, and reservoirs of Leishmania spp.), these species are also implicated in the
epidemiology of several zoonotic geohelminths such as Toxocara spp., Ancylostoma spp. (e.g.,
Ancylostoma caninum and Ancylostoma braziliense) and Strongyloides stercoralis, and cestodes
(e.g., Dipylidium caninum), entailing direct or indirect transmission through an intermediate
host (e.g., fleas and Trichodectes lice in the case of D. caninum) [76,82]. The frequent free-
roaming behaviour of dogs and cats, typically in rural milieus across Africa [83], coupled
with the usually poor hygiene and water sanitation of such settings, can particularly favour
the spread of these parasitoses and enhance exposure risks in humans and other animal
species. In addition, with the size of middle class rising in the continent [84], ownership
of dogs and cats as “pets” may potentially increase in urban areas in the next decades,
highlighting the importance of parasite control also in urban and peri-urban sites, where
encounters between “owned” and “free-roaming” animals, and their excretions, may occur.
Furthermore, the contribution of wildlife needs also to be considered, either as defini-
tive (e.g., lions and hyenas for Echinoccocus felidis) or intermediate hosts (e.g., warthogs
for E. felidis) or even reservoirs (rodents in the case of Schistosoma spp.) of zoonotic para-
sites [85,86]. Therefore, in order to be fully and durably effective, One Health initiatives
tackling parasitic conditions should aim to tackle all final, intermediate, potentially vector
and even paratenic or transport hosts involved in life cycles of target aetiological agents.
Overlooking even a single host species, wildlife included, can indeed cause the reappear-
ance or impede the elimination tout court of cases of infection or disease in certain other
hosts, despite generous control efforts being addressed towards them.
3. One Health beyond Parasitic Zoonoses
Should the One Health approach be envisaged only in the case of zoonotic parasitic or
arthropod-borne infections that are shared between humans and animals? This concept
paper advocates for a more comprehensive assessment of parasites and vectors in this
paradigm. The health of livestock (e.g., cattle, sheep, goats, camels, poultry, pigs, donkeys,
etc.) in Africa is indeed undermined by several parasites or arthropods that, although not
zoonotic per se, cause major chronic deterioration and productivity losses, being responsi-
ble for low body condition scoring, poor protein conversion and, overall, scarce production
(i.e., in milk, meat, eggs and skins). In the case of cattle, for instance, gastrointestinal
nematodes, ticks and tick-borne infections and animal African trypanosomiasis are the
most important examples to be incriminated in these regards [87]. The productivity losses
that they entail are therefore inextricably connected with the continent’s food insecurity,
especially considering that the largest bulk of Africa’s food production is used for local con-
sumption [14]. With food insecurity being recognised as a global health challenge [10,55],
all its major causes in the animal sources should be thoroughly investigated and tackled
under the One Health lens. This applies also to animals’ and livestock parasitic infections,
given the burden they pose, ultimately, to human sustainment and nutrition. As the OIE
puts it, “pathogens of animal origin that are not transmissible to humans, but which have a
severe impact on the production of animal protein, should not be neglected either, particu-
larly in developing countries. In fact, they can lead to production losses and a reduction
in the available food supply, leading to serious public health problems caused by food
shortages and protein deficiencies” [55].
4. One Health Approach for Research and Development of Parasiticides
The field of research and development (R&D) of parasiticides provides perhaps the
most blatant concrete examples of the One Health approach in parasitology, spanning
across human and veterinary medicine. The possibly most renowned case in point in this
respect is represented by the “wonder drug” ivermectin. Discovered in the late 1970s and
initially developed for veterinary use as a broad-spectrum endectocide targeting gastro-
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intestinal nematodes and several ectoparasitic arthropods, ivermectin has then been largely
employed in human medicine for the control of onchocerciasis, lymphatic filariasis (LF),
certain soil-transmitted helminthiases (e.g., by Ascaris lumbricoides and S. stercoralis) and
scabies [88]. This drug still represents the mainstay of two global campaigns aiming to
eliminate onchocerciasis and LF, by the means of Mass Drug Administration (MDA), made
possible through donations of the active ingredient (produced under the brand name
Mectizan®) by Merck & Co., Inc. (Kenilworth, NJ, USA) (for LF, ivermectin is administered
in combination with the anthelmintic albendazole, donated by GlaxoSmithKline, GSK) [89].
Recently, the use of ivermectin was proposed for MDAs in both humans and livestock as a
complementary strategy to control malaria mosquito vectors [90].
Another successful example of an anthelmintic employed in both human and veteri-
nary medicine is that of praziquantel. Also discovered in the 1970s, it is used to control
cestodes and trematodes in dogs, cats, horses [91] and sometimes even cattle [92], and
it represents the only currently available option for the control of schistosomiasis in hu-
mans [93]. Over the years, praziquantel has indeed been used for MDA-based preventative
chemotherapy (PC) campaigns targeting school aged children in schistosomiasis-endemic
areas in Africa [93].
However, risks of emergence and/or spreading of resistance or reduced efficacy in
human parasites addressed towards ivermectin (i.e., in Onchocerca volvulus) [94,95] and
praziquantel (i.e., in Schistosoma spp.) [96], together with the need for effective drugs
and/or vaccines against NTDs and malaria, have paved the way for initiatives aiming to
fill the void in R&D pipelines against these diseases. Indeed, from the early 2000s onwards,
several “Product Development Partnerships” (PDPs) started being established, under the
model of “Public–Private Partnerships” (PPPs). These include, among others, the Drugs for
Neglected Diseases initiative (DNDi) [97], Medicines for Malaria Venture (MMV) [98] and
the Global Health Innovation Technology (GHIT) [99], focused on drug and/or vaccine de-
velopment; the Foundation for Innovative Diagnostics (FIND) [100] devoted to diagnostics;
the Program for Appropriate Technology in Health (PATH) [101] dedicated to vaccine R&D,
primary health care and advocacy; and the Innovative Vector Control Consortium (IVCC),
developing vector control tools [102]. Such PDPs are non-profit entities that collaborate
with human pharmaceutical and biotech firms to support them in the development of solu-
tions to address NTDs and malaria (e.g., from discovery to clinical trials and registration).
Within this framework, the substantial funding provided by multilateral, bilateral and
philanthropic donors (e.g., Bill & Melinda Gates Foundation), allows for the “de-risking”
of R&D projects that would otherwise be prohibitive for industry alone, due to the limited
return on investment (ROI) that they may generate (being NTDs and malaria, by definition,
the diseases of the poor) [103,104]. The execution of the London Declaration on NTDs
in 2012, which gathered initially the world’s 13 leading pharmaceutical companies, gen-
erated a major momentum in the fight against NTDs, catalysing an investment of more
US$785 million to support R&D programmes [105].
For example, DNDi’s target conditions include several parasitic NTDs that are endemic
to the African continent such as leishmaniasis, sleeping sickness (trypanosomiasis), LF
and onchocerciasis [106]. With respect to the latter condition, DNDi’s efforts are currently
focused on evaluating emodepside, an anthelminthic veterinary drug used to control
nematodes in cats and dogs, for the development of an oral macrofilaricidal treatment for
onchocerciasis in humans, to be delivered as a tablet [107]. Following successful Phase I
studies in healthy volunteers, this project will soon undergo a Phase II proof-of-concept
clinical trial in Ghana, aiming to assess the safety and efficacy of emodepside for people
living with onchocerciasis [108].
In the veterinary field, the Global Alliance for Livestock Veterinary Medicine (GALVmed)
was established in 2004 as a PDP supporting veterinary pharmaceutical companies de-
veloping drugs, vaccines and diagnostic tools for livestock diseases of poor smallholder
farmers in sub-Saharan Africa and South Asia (e.g., India, Bangladesh and Nepal) [109].
Some of GALVmed’s target diseases include NZDs such as porcine cysticercosis and animal
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African trypanosomiasis and the zoonotic arthropod-borne RVF [110]. In the case of porcine
cysticercosis, GALVmed bolstered the commercial development of a dual approach based
on the first licensed cysticercosis vaccine for pigs (i.e., TSOL18), administered concurrently
with a therapeutic drug (i.e., oxfendazole), used to eliminate parasitic larvae, according to
a “therapeutic-prevention” strategy [111]. Following successful trials in Nepal, Tanzania,
Uganda and Zambia, both products are now undergoing registration in several African
countries [112]. Given the zoonotic nature of cysticercosis, this initiative is expected to
bring also public health benefits to the communities administering these products to their
pigs.
The examples of dewormers such as ivermectin and praziquantel show that oppor-
tunities do exist with regards to translating or even “repurposing5” drug discovery and
development from human to veterinary health applications, and vice versa, in the area
of parasitic infections. Considering the importance of nematodes and arthropod pests in
agriculture, both veterinary and human pharmaceutical industries can potentially benefit
from collaborations with agrochemical firms in this space. However, depending on the
epidemiological settings, risks of emergence of resistance or reduced efficacy in humans
due to the widespread use of a given compound or class in animals, not only should be
anticipated, but should also be avoided, learning from the experiences with antimicrobial
use. It would therefore be desirable that veterinary and human pharmaceuticals’ R&D
efforts, while still synergising on potential repurposing efforts, would also deliver “com-
plementary” therapeutic options that would allow for the sustainable and yet effective
management of infections across all concerned host species, minimising the risks of resis-
tances by relying on different modes of actions, when possible. Given the wider occurrence
of parasites in animals compared to humans and considering the profitable market of vet-
erinary parasiticides (including ectoparasiticides, endoparasiticides and endectocides) in
the developed world [85], it should not be excluded that the experience generated in animal
health R&D programmes could prove useful for humans too. Because of this, establishing
dedicated fora of communication exchange among human and veterinary pharmaceutical
firms, in the spirit of the London Declaration, may bring benefits to global public health.
At the same time, potential changes of distribution patterns of certain insect-borne NTDs
(e.g., dengue and chikungunya), due to global warming, may lead, in future decades, to
an increase of their prevalence in more mildly temperate high-income countries [113,114].
This may provide an ROI-driven impetus prompting more R&D ventures, also in the area
of vector control, for both developing and developed countries.
5. Perspectives from Here
Considering the review above, this concept note upholds a number of recommenda-
tions, to be taken into account when dealing with parasitic and arthropod-borne infections
in Africa and beyond, in current COVID-19 times and further. Such recommendations not
only are addressed to the attention of medical and veterinary parasitologists and entomol-
ogists, but also to the general public, social scientists, public health, pharmaceutical and
biotech industry professionals and policy-makers.
This appraisal underpins that, for it to be effective, the One Health approach should
be adopted or, rather, embraced, through a holistic, global, interdisciplinary, multisectoral,
harmonised and forward-looking set of actions (see also Figure 1). Below will be provided
elaborations for each of the adjectives used to define the One Health model here recom-
mended.
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Figure 1. Proposed One Health model, addressed to medical and veterinary parasitologists and entomologists, as well
as general public, social scientists, public health, pharmaceutical and biotech industry professionals and policy-makers,
dealing with parasitic and vector-borne infections, in Africa and beyond.
i. The holistic perspective of the One Health approach here recommended encourages
the involvement of parasitologists in issues pertaining not only to (i) mere parasitic
conditions of humans and animals, but also to (ii) vector-borne infections caused by
other pathogens (e.g., viruses and bacteria), entailing nevertheless parasitic arthro-
pods in their epidemiology and therefore requiring entomological expertise in order
to be tackled comprehensively and effectively. Moreover, the present analysis sug-
gests that parasitologists should consider under the One Health approach not only
(i) zoonoses, but also (ii) non-zoonotic veterinary parasitoses responsible for produc-
tivity losses in livestock, thus for food insecurity in their respective communities.
With the role of agriculture being as fundamental to Africa’s ongoing and future
socio-economic development, the analysis here provided underscores the indissolu-
bility, when dealing with parasitic and vector-borne infections according to the One
Health approach, of concepts such as (i) human health and (ii) animal health, as well
as (iii) environment (e.g., plant and biodiversity’s) health. Afterall, the well-being of
humans, animals and the environment is inextricably linked to agriculture and its
several practices (e.g., agribusiness, agroecology, agroforestry and pastoralism) and to
the management and use of wild resources, including flora, fauna and water. Accord-
ingly, the durable insurance of the well-being of human beings and their livestock will
necessarily need to encompass the preservation of habitats and biodiversity richness.
ii. The global nature of this effort stems from the realisation that no public health is-
sue has a merely local dimension, as it has been clearly shown by the COVID-19
pandemic. In the case of parasitic and vector-borne infections, there is no condition
that can be considered as a null threat outside where it originates, especially if naïve
areas of potential novel introduction harbour suitable habitats for the parasite or its
intermediate host(s) or vector(s) to develop. For example, this is evidently the case
for food-borne parasitoses (e.g., echinococcosis, toxoplasmosis and trematodiases)
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that could be carried to significant distances through trade of food produces [115] or
for infections that can reach new areas through movement of infective vectors (e.g.,
mosquitoes) or intermediate hosts (e.g., snails) via human-made means of transports
(e.g., airplanes or ships) [116–118] or by dispersion of vectors through migratory birds
(e.g., Hyalomma ticks parasitising migratory birds and posing risks of new foci of
CCHF) or other parasitised hosts [118–120] or through travel of infected hosts [118].
In the latter case, it should however be noted that a population of competent vectors
would need to occur in the area of new introduction for such a vector-borne infection
to successfully establish [118].
Undoubtedly, practicing the One Health approach globally requires great coop-
eration and coordination among institutions at national, regional, continental and
intercontinental level, to ensure the constant exchange of information and the con-
tinuous advancement of surveillance and response systems. This should be done
with the awareness that exchanging information among countries or regions can
provide mutual benefits in terms of capacity building and thus preparedness and
responsiveness in all geographies involved in such a dialogue. Accordingly, improv-
ing capacity in Europe on the detection and surveillance of “exotic” vector-borne
infections that are currently endemic in some parts of Africa, such as RVF, can also
provide enhanced training opportunities to African scientists and researchers, who,
in turn, may further potentiate their monitoring systems by exchanging views and
personnel with non-endemic third countries.
iii. The interdisciplinary angle of this effort requires the consideration of parasitic and
arthropod-borne infections under the lens of both life sciences and social sciences.
Indeed, all types of control efforts can only be effective in a given area (from small to
large, regardless of its size) if designed, implemented and evaluated by taking into
account the social determinants of health, in which people are born, grow, live, work
and age. These include factors like socio-economic status, education, neighbourhood
and physical environment, employment, and social support networks, as well as
access to health care of communities [121]. The involvement and “ownership” of local
communities, that are the ultimate beneficiaries of interventions, whether treatments
are addressed to humans or animals or the environment, should indeed be mandatory
for all One Health (and beyond) interventions, dealing with all types of conditions,
not only parasitic ones. Only a deep understanding of communities’ practices and
customs can allow for the conception of potentially effective initiatives, which should
be co-designed with recipient communities.
For example, in the early 2010s, conversations with cattle keepers from northern
Uganda (i.e., districts of Kaberamaido and Dokolo), reporting of being not rarely
bitten by “colourful” ornate ticks (i.e., Amblyomma spp.) led to documenting for the
first time in the country the occurrence of the zoonotic pathogen R. africae, causative
agent of African Tick-Bite Fever (ATBF) [122], a condition often misdiagnosed with
malaria- or flu-like syndromes [123]. Such finding highlighted the risk of exposure
to ATBF of rural communities in northern Uganda, underpinning the importance of
raising awareness on this rickettsiosis, particularly among persons handling cattle
(e.g., herders, veterinarians and paraveterinarians) as well as among physicians
practicing in these areas, and those who care for returning travellers [122]. It is thanks
to farmers’ viewpoints that this investigation could be started, and such a public
health risk could be unveiled.
iv. The multisectoral nature of the approach here recommended entails the participation in
One Health initiatives of all stakeholders potentially concerned, including civil society,
academia, industry, institutions and their policy-makers. All parties’ contribution is
essential for interventions to be successful. Academic parasitologists should therefore
strive for engaging with civil society any time the investigations that they conduct
may have possible repercussions on the latter. With data in hand, parasitologists as
other scientists in the field of One Health, should engage in societal debate and render
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their research rationales, methodologies, findings and recommendations intelligible
not only to the general public, but also to administrators. To some extent, the COVID-
19 pandemic has shown that concepts such as antigenic or serological testing or even
that of One Health itself, can become more widely accessible than they used to be
beforehand, out of necessity. At the same time, academics and industry actors should
proactively seek to collaborate with each other. The contribution of the private sector
(e.g., pharmaceutical/biotech/vector control industries) is indeed essential in the
fight against parasitic and vector-borne infections, as it allows to deliver “ready to
use” solutions such as drugs, vaccines, insecticides and diagnostic tools. At the same
time, serendipities happening in laboratories at universities and research institutes
can lead to breakthrough discoveries that could be ultimately turned into “actual
products”, responding to unmet needs on the ground, through win-win partnerships
with the private sector.
v. With multiple programmes being often conducted concurrently in neighbouring, if not
overlapping, geographic areas, addressing either the same or different diseases, there
is a need for harmonised actions. These would be possible through the establishment
of a steady dialogue among key actors of projects’ cycles, including programmers
and formulators (e.g., donors, local authorities and communities), implementers
(e.g., funding grantees, principal investigators, programme coordinators, etc.) and
monitoring and evaluation teams. Creating, whenever possible, synergies between
incoming projects and previous and/or concomitant initiatives can allow to optimise
results and minimise possible redundancies and “stakeholder fatigue”, for the sake of
the common good. With global health gaining presumably increasingly more political
attention in the wake of the COVID-19 pandemic [124–126], prioritising interventions
based on burden of diseases (e.g., through Disability-Adjusted Life Years (DALY)) is
undoubtedly an important instrument for agenda setting. In this view, the availability
of reliable data, generated through robust methodologies and thorough analyses, is
essential.
vi. Finally, for it to be “ever topical” and effective, the One Health approach should
also be forward-looking, and rely on institutional policies fostering (a) research and
innovation, both at public and private level, and (b) continuing education and training
in parasitology and entomology. Only through constant R&D efforts, entailing collab-
orations among academia, industry and PDPs, it can be hoped that more parasitic and
arthropod-borne conditions of humans and animals or both, NTDs included, could
be effectively controlled in the future. Fostering research and innovation as well as
manufacturing capacity locally in Africa, not only could prove logistically practical
and ultimately cost-effective, considering these efforts are addressed to endemic
conditions of the continent, but can also provide the African burgeoning youth with
major employment opportunities. This would also require tailored curricula to be put
in place at local African universities. The know-how built by the Institut Pasteur de
Dakar, only centre in Africa able to produce a yellow fever vaccine [127] and soon to
produce vaccines against COVID-19 [128], as well as the institution of the University
of Global Health Equity in Rwanda [129] and the One Health Research, Education
and Outreach Centre in Africa (OHRECA) in Kenya [130] and the Africa One Health
University Network (AFROHUN) [131] are just some encouraging examples in this
respect, among other ongoing initiatives. Importantly, given the centrality of youth
in education and the fundamental contribution of women scientists to Africa’s de-
velopment [132], investing in research, innovation and training in parasitology and
entomology can have an immensely empowering role and contribute to the overall
attainment of the United Nations’ 2030 Agenda’s SDG #4 (“quality education”) and
SDG #5 (“gender equality”).
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6. Conclusions
From this analysis, it may appear evident that tackling parasitic conditions and
arthropod-borne infections of humans and animals through the One Health approach can
tangibly help the attainment of SDGs pertaining to poverty alleviation, food security and
health, such as SDG #1 (“no poverty”), SDG #2 (“zero hunger”) and SDG #3 (“good health
and well-being”). Furthermore, managing these infections as holistically and collabora-
tively as advocated in this paper may also allow the fulfilment of other interconnected
SDGs, such as #6 (“clean water and sanitation”) (e.g., with special regards to water-borne
parasitic conditions such as schistosomiasis, trematodiases and also a number of arthropod-
borne infections requiring running or stagnant waters for the development of arthropod
vectors), SDG #8 (“decent work and economic growth”), SDG #10 (“reduced inequalities”),
SDG #15 (“life on land”), SDG #17 (“partnerships for the goals”) and, indeed, SDG #4 and
SDG #5 aforementioned.
All in all, the approach here proposed is consistent with the concept of “Planetary
Health” [133], according to which the potential participation of the UN Environmental
Programme (UNEP) to the FAO–OIE–WHO Tripartite collaboration may further strengthen
the overall governance of One Health initiatives in Africa and at a global scale [134]. Despite
their heavy burden, parasitic and arthropod-borne infections are still one part of a large
number of issues that need to be managed under the One Health lens in Africa, including,
among others, antimicrobial resistance, rabies, Ebola and COVID-19. With parasitoses
usually lasting longer than the time of an “epidemic”, addressing these effectively could
allow long(er)-term investments in sustainable resilient health systems, that could, in turn,
enhance preparedness and responsiveness, whenever needed, vis-à-vis other public health
challenges. Let us roll up our sleeves.
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Glossary
1. Zoonoses or zoonotic infections: Infections that are naturally transmitted from vertebrate
animals to humans, and vice versa [64]. Zoonotic diseases are therefore conditions derived
from such infections.
2. Demographic dividend: Economic growth deriving from shifts in a population’s age structure,
mainly when the share of the working age population (15–64-year-olds) is larger than the non-
working age share of the population (<14-year-olds and >65-year-olds). This can occur when
declining fertility leads to a bulge in the proportion of the population entering the labour force,
in the presence of suitable jobs. If this young cohort is healthy, well-educated and empowered,
and has a chance for decent work, it can accelerate sustainable development in the course of a
generation [135].
3. Parasitologists: Scientists devoted to the study of internal and/or external parasites (i.e.,
endoparasites (e.g., protozoa, nematodes, trematodes and cestodes) and ectoparasites (e.g.,
parasitic arthropods), respectively). The definition employed in this text is inclusive of that of
entomologists (scientists devoted to the study of insects and other classes of arthropods).
4. Endectocides: Antiparasitic products able to kill and control both internal (i.e., endoparasites)
and external parasites (i.e., ectoparasites). Endoparasites usually controlled by endectocides
include nematodes (e.g., gastrointestinal and/or bronchopulmonary nematodes), whereas
target ectoparasites may vary according to the active compounds used, possibly including
mange mites, one host-ticks (i.e., Boophilus spp.), fly larvae, etc. A typical example of endectocide
is provided by products based on ivermectin and other compounds of the class of macrocyclic
lactones (e.g., doramectin, moxidectin, milbemycin oxime, etc.).
5. Repurposing (or repositioning): The process of finding new uses outside the scope of the
original medical indication of a drug [136].
References
1. Agence Française de Développement (AFD). AFD’s Atlas of Africa: Viewing the Continent from a New Angle. Published on 16
September 2020. Available online: https://www.afd.fr/en/actualites/afds-atlas-africa-viewing-continent-new-angle (accessed
on 23 September 2021).
2. Institut National d’études Démographiques (INED). WORLD–Estimations 2021. Available online: https://www.ined.fr/en/
everything_about_population/data/all-countries/ (accessed on 27 September 2021).
3. Institut National d’études Démographiques (INED). Projections by Continent. Update: November 2019. Available online:
https://www.ined.fr/en/everything_about_population/data/world-projections/projections-by-continent/ (accessed on 27
September 2021).
4. Food and Agriculture Organization (FAO). Africa Sustainable Livestock 2050; Animal Production and Health Report. No. 12; FAO:
Rome, Italy, 2017. Available online: http://www.fao.org/3/ai7222e (accessed on 27 September 2021).
5. Food and Agriculture Organization (FAO). The Future of Food and Agriculture–Alternative Pathways to 2050; Supplementary Material;
FAO: Rome, Italy, 2018; p. 64.
6. World Bank. Business and Livelihoods in African Livestock: Investments to Overcome Information Gaps; World Bank: Washington, DC,
USA, 2014. Available online: https://openknowledge.worldbank.org/handle/10986/17801 (accessed on 27 September 2021).
7. Rakotoarisoa, M.A.; Iafrate, M.; Paschali, M.; Food and Agriculture Organization (FAO). Why Has Africa Become a Net Food
Importer? Explaining Africa Agricultural and Food Trade Deficits; Trade and Markets Division: Rome, Italy, 2011.
8. African Development Bank (AfDB). Feed Africa. The High 5 for Transforming Africa. Available online: https://www.afdb.org/
en/the-high-5/feed-africa (accessed on 27 September 2021).
9. Food and Agriculture Organization (FAO). New UN Report Reveals that Hunger in Africa Continues to Rise. 13 February 2019.
Available online: http://www.fao.org/news/story/en/item/1180443/icode/ (accessed on 27 September 2021).
10. FAO; IFAD; UNICEF; WFP; WHO. The State of Food Security and Nutrition in the World 2021. Transforming Food Systems for Food
Security, Improved Nutrition and Affordable Healthy Diets for All; FAO: Rome, Italy, 2021. [CrossRef]
11. Akombi, B.J.; Agho, K.E.; Merom, D.; Renzaho, A.M.; Hall, J.J. Child malnutrition in sub-Saharan Africa: A meta-analysis of
demographic and health surveys (2006–2016). PLoS ONE 2017, 12, e0177338. [CrossRef] [PubMed]
12. World Health Organization (WHO). Regional Office for Africa. Obesity. Overview. Available online: https://www.afro.who.int/
health-topics/obesity#:~{}:text=Once%20considered%20a%20high%2Dincome,to%2010.6%20million%20in%202014 (accessed on
27 September 2021).
Pathogens 2021, 10, 1437 15 of 19
13. Africa Development Bank (AfDB). Feed Africa: Strategy for Agricultural Transformation in Africa 2016–2025. May 2016.
Available online: https://www.afdb.org/fileadmin/uploads/afdb/Documents/Generic-Documents/Feed_Africa-_Strategy_
for_Agricultural_Transformation_in_Africa_2016-2025.pdf (accessed on 24 September 2021).
14. IFAD. The Field Report. Available online: https://www.ifad.org/thefieldreport/ (accessed on 28 September 2021).
15. Jayaram, K.; Riese, J.; Sanghvi, S. Agriculture: Abundant Opportunities. McKinsey Quarterly, Summer 2010. Available online:
https://www.mckinsey.com/featured-insights/middle-east-and-africa/africas-path-to-growth-sector-by-sector (accessed on 29
September 2021).
16. African Union Development Agency (AUDA)-NEPAD. Comprehensive Africa Agriculture Development Programme (CAADP).
Available online: https://www.nepad.org/cop/comprehensive-africa-agriculture-development-programme-caadp (accessed on
27 September 2021).
17. New Alliance for Food Security and Nutrition. Available online: https://newalliance.travelvisabookings.com/about (accessed
on 27 September 2021).
18. Bacchi, U. Can Africa Deal with an Expected Boom in Demand for Meat? Thomson Reuters Foundation. 13 March 2017. Available
online: https://www.reuters.com/article/us-africa-food-livestock-idUSKBN16K1V3 (accessed on 27 September 2021).
19. Africa Group of Negotiators experts Support (AGNES). Desertification and Climate Change in Africa. Policy Brief No. 1. March
2020, pp. 1–8. Available online: https://agnes-africa.org/wp-content/uploads/2020/07/Policy-brief-1_Desertification-_Final_
09032020.pdf (accessed on 27 September 2021).
20. Steinfeld, H.; Gerber, P.; Wassenaar, T.; Castel, V.; Rosales, M.; De Haan, C. Livestock’s Long Shadow: Environmental Issues and
Options; FAO: Rome, Italy, 2006; p. 414, ISBN 978-92-5105571-7. Available online: http://www.fao.org/docrep/010/a0701e/a070
1e00.HTM (accessed on 29 September 2021).
21. African Development Bank (AfDB). Urbanization in Africa. 13 December 2012. Available online: https://blogs.afdb.org/fr/
inclusive-growth/urbanization-africa-191 (accessed on 27 September 2021).
22. Latino, L.R.; Pica-Ciamarra, U.; Wisser, D. Africa: The livestock revolution urbanizes. Glob. Food Sec. 2020, 26, 100399. [CrossRef]
[PubMed]
23. Neiderud, C.J. How urbanization affects the epidemiology of emerging infectious diseases. Infect. Ecol. Epidemiol. 2015, 5, 27060.
[CrossRef] [PubMed]
24. Hassell, J.M.; Begon, M.; Ward, M.J.; Fèvre, E.M. Urbanization and disease emergence: Dynamics at the wildlife-livestock-human
interface. Trends Ecol. Evol. 2017, 32, 55–67. [CrossRef] [PubMed]
25. Nguimkeu, P.; Tadadjeu, S. Why is the number of COVID-19 cases lower than expected in Sub-Saharan Africa? A cross-sectional
analysis of the role of demographic and geographic factors. World Dev. 2021, 138, 105251. [CrossRef]
26. Kulohoma, B.W. COVID-19 risk factors: The curious case of Africa’s governance and preparedness. Sci. Afr. 2021, 13, e00948.
27. Ezeh, A.; Silverman, M.; Stranges, S. The Conversation. The Impact of COVID-19 Has Been Lower in Africa. We Explore the
Reasons. Contributor: Adams, J. 17 August 2021. Available online: https://theconversation.com/the-impact-of-covid-19-has-
been-lower-in-africa-we-explore-the-reasons-164955 (accessed on 27 September 2021).
28. Gondwe, G. Assessing the Impact of COVID-19 on Africa’s Economic Development. UNCTAD/ALDC/MISC/2020/3. July 2020,
p. 21. Available online: https://unctad.org/system/files/official-document/aldcmisc2020d3_en.pdf (accessed on 27 September
2021).
29. Barlow, P.; van Schalkwyk, M.C.; McKee, M.; Labonté, R.; Stuckler, D. COVID-19 and the collapse of global trade: Building an
effective public health response. Lancet Planet. Health 2021, 5, e102–e107. [CrossRef]
30. Ali Mohamed, E.M.; Alhaj Abdallah, S.M.; Ahmadi, A.; Lucero-Prisno, D.E. Food Security and COVID-19 in Africa: Implications
and Recommendations. Am. J. Trop. Med. Hyg. 2021, 104, 1613–1615. [CrossRef]
31. Oxford Business Group. Agriculture in Africa 2021: Focus Report. In Collaboration with OCP. April 2021. Available online:
https://oxfordbusinessgroup.com/blog/bernardo-bruzzone/focus-reports/agriculture-africa-2021-focus-report (accessed on 26
September 2021).
32. World Bank. GDP (Current US$)-Sub-Saharan Africa. Available online: https://data.worldbank.org/indicator/NY.GDP.MKTP.
CD?locations=ZG (accessed on 28 September 2021).
33. Amankwah, A.; Gourlay, S. Food Security in the Face of COVID-19. Evidence from Africa. January 2021. Living Standards
Measurement Study & World Bank Group. Available online: https://documents1.worldbank.org/curated/en/9126616109643724
85/pdf/Food-Security-in-the-Face-of-COVID-19-Evidence-from-Africa.pdf (accessed on 23 September 2021).
34. OECD/FAO. Agriculture in Sub-Saharan Africa: Prospects and challenges for the next decade. In OECD-FAO Agricultural Outlook
2016–2025; OECD Publishing: Paris, France, 2016; Part I; Chapter 2.
35. FAO; IFAD; WFP. The State of Food Insecurity in the World 2015. Meeting the 2015 International Hunger Targets: Taking Stock
of Uneven Progress, Food and Agriculture Organization Publications. 2015. Available online: https://www.fao.org/policy-
support/tools-and-publications/resources-details/en/c/469455/ (accessed on 28 September 2021).
36. World Bank. Rural Population (% of Total Population)-Sub-Saharan Africa. Available online: https://data.worldbank.org/
indicator/SP.RUR.TOTL.ZS?locations=ZG (accessed on 28 September 2021).
37. Mercandalli, S.; Losch, B. Rural Migration in Sub−Saharan Africa: Patterns, Drivers and Relation to Structural Transformation;
Belebema, M.N., Bélières, J.-F., Bourgeois, R., Dinbabo, M.F., Fréguin-Gresh, S., Mensah, C., Nshimbi, C.C., Eds.; FAO and CIRAD:
Rome, Italy, 2019. [CrossRef]
Pathogens 2021, 10, 1437 16 of 19
38. NEPAD. African Agriculture, Transformation and Outlook; NEPAD: Johannesburg, South Africa, 2013; 72p.
39. Heidhues, F.; Brüntrup, M. Subsistence agriculture in development: Its role in processes of structural change. In Subsistence
Agriculture in Central and Eastern Europe: How to Break a Vicious Cycle? Abele, S., Frohberg, K., Eds.; Studies on the Agricultural
and Food Sector in Central and Eastern Europe; Institute of Agricultural Development in Central and Eastern Europe (IAMO):
Halle, Germany, 2003; Volume 22.
40. Khalil, C.A.; Conforti, P.; Ergin, I.; Gennari, P. Food and Agriculture Organization (FAO). Defining Small-Scale Food Producers to
Monitor Target 2.3 of the 2030 Agenda for Sustainable Development; Working Paper Series ESS/17-12; FAO Statistics Division: Rome,
Italy, 2017.
41. Murphy, S. Changing Perspectives: Small-Scale Farmers, Markets and Globalization (Revised Edition); IIED/Hivos: London/The Hague,
UK, 2012.
42. World Bank. Reaching the Rural Poor: A Renewed Strategy for Rural Development; World Bank: Washington, DC, USA, 2003. Available
online: https://openknowledge.worldbank.org/handle/10986/14084 (accessed on 28 September 2021).
43. Jayne, T.S.; Chamberlin, J.; Traub, L.; Sitko, N.; Muyanga, M.; Yeboah, F.K.; Anseeuw, W.; Chapoto, A.; Wineman, A.; Nkonde,
C.; et al. Africa’s changing farm size distribution patterns: The rise of medium scale farms. Agric. Economics 2016, 47, 197–214.
[CrossRef]
44. Jayne, T.S.; Muyanga, M.; Wineman, A.; Ghebru, H.; Stevens, C.; Stickler, M.; Chapoto, A.; Anseeuw, W.; van der Westhuizen, D.;
Nyange, D. Are medium-scale farms driving agricultural transformation in sub-Saharan Africa? Agric. Econ. 2019, 50, 75–95.
[CrossRef]
45. FARM Africa. Our Work with Livestock. Available online: https://www.farmafrica.org/agriculture/livestock (accessed on 28
September 2021).
46. Otte, M.J.; Chilonda, P. Cattle and Small Ruminant Production Systems in Sub-Saharan Africa. A Systematic Review; Food and
Agriculture Organization (FAO): Rome, italy, 2002; p. 98.
47. De Leeuw, J.; Osano, P.; Said, M.; Ayantunde, A.; Dube, S.; Neely, C.; Vrieling, A.; Thornton, P.; Ericksen, P. The pastoral farming
system. Balancing between tradition and transition. In Farming Systems and Food Security in Africa, 1st ed.; Dixon, J., Ed.; Routledge:
London, UK, 2019; pp. 318–353.
48. FAO. Pastoralism in Africa’s Drylands; FAO: Rome, Italy, 2018; p. 52.
49. Avis, W. Rebuilding Pastoralist Livelihoods during and after Conflict; K4D Helpdesk Report 421; Institute of Development Studies:
Brighton, UK, 2018.
50. Grace, D.; Lindahl, J.; Wanyoike, F.; Bett, B.; Randolph, T.; Rich, K.M. Poor livestock keepers: Ecosystem-poverty-health
interactions. Philos Trans R Soc Lond B Biol Sci. 2017, 372, 20160166. [CrossRef]
51. Herrero, M.; Addison, J.; Bedelian, C.; Carabine, E.; Havlík, P.; Henderson, B.; Van De Steeg, J.; Thornton, P.K. Climate change
and pastoralism: Impacts, consequences and adaptation. Rev. Sci. Tech. Off. Int. Epiz. 2016, 35, 417–433. [CrossRef]
52. Roesel, K.; Grace, D. (Eds). Food Safety and Informal Markets: Animal Products in Sub-Saharan Africa; Routledge: London, UK, 2014.
53. AUDA-NEPAD. Strengthening Rural Decent Jobs in Africa. 26 November 2020. Available online: https://www.nepad.org/
news/strengthening-rural-decent-jobs-africa (accessed on 28 September 2021).
54. World Health Organization (WHO). Food and Agriculture Organization of the United Nations (FAO) and World Organisation for
Animal Health (OIE) Taking a Multisectoral, One Health Approach: A Tripartite Guide to Addressing Zoonotic Diseases in Coun-
tries. 2019. Available online: https://www.oie.int/fileadmin/Home/eng/Media_Center/docs/EN_TripartiteZoonosesGuide_
webversion.pdf (accessed on 25 September 2021).
55. World Organisation for Animal Health (OIE). One Health. Available online: https://www.oie.int/en/what-we-do/global-
initiatives/one-health/ (accessed on 25 September 2021).
56. European Union. Global Health Summit. Rome Declaration. Available online: https://global-health-summit.europa.eu/rome-
declaration_en (accessed on 28 September 2021).
57. Njoroge, M.M.; Tirados, I.; Lindsay, S.W.; Vale, G.A.; Torr, S.J.; Fillinger, U. Exploring the potential of using cattle for malaria
vector surveillance and control: A pilot study in western Kenya. Parasites Vectors. 2017, 10, 18. [CrossRef]
58. Waite, J.L.; Swain, S.; Lynch, P.A.; Sharma, S.K.; Haque, M.A.; Montgomery, J.; Thomas, M.B. Increasing the potential for malaria
elimination by targeting zoophilic vectors. Sci. Rep. 2017, 7, 40551. [CrossRef]
59. Khaligh, F.G.; Jafari, A.; Silivanova, E.; Levchenko, M.; Rahimi, B.; Gholizadeh, S. Endectocides as a complementary intervention
in the malaria control program: A systematic review. Syst. Rev. 2021, 10, 30. [CrossRef]
60. Hewitt, S.; Rowland, M. Control of zoophilic malaria vectors by applying pyrethroid insecticides to cattle. Trop. Med. Int. Health
1999, 4, 481–486. [CrossRef]
61. WHO. Ending the Neglect to Attain the Sustainable Development Goals: A Road Map for Neglected Tropical Diseases 2021–2030; World
Health Organization: Geneva, Switzerland, 2020.
62. Khetarpal, N.; Khanna, I. Dengue Fever: Causes, Complications, and Vaccine Strategies. J. Immunol. Res. 2016, 2016, 6803098.
[CrossRef]
63. Vairo, F.; Haider, N.; Kock, R.; Ntoumi, F.; Ippolito, G.; Zumla, A. Chikungunya: Epidemiology, Pathogenesis, Clinical Features,
Management, and Prevention. Infect. Dis. Clin. N. Am. 2019, 33, 1003–1025. [CrossRef]
64. WHO. Control of Neglected Tropical Diseases. Neglected Zoonotic Diseases. Available online: https://www.who.int/teams/
control-of-neglected-tropical-diseases/neglected-zoonotic-diseases (accessed on 27 September 2021).
Pathogens 2021, 10, 1437 17 of 19
65. Welburn, S.C.; Beange, I.; Ducrotoy, M.J.; Okello, A.L. The neglected zoonoses—The case for integrated control and advocacy.
Clin. Microbiol. Infect. 2015, 21, 433–443. [CrossRef]
66. United Nations. General Assembly. Seventieth Session. Resolution Adopted by the General Assembly on 25 September 2015.
Available online: https://www.un.org/ga/search/view_doc.asp?symbol=A/RES/70/1&Lang=E (accessed on 29 September
2021).
67. Uniting to Combat Neglected Tropical Diseases. Ten Achievements of the London Declaration on Neglected Tropical Diseases
Posted: 30 January 2020. Available online: https://unitingtocombatntds.org/news/ten-achievements-of-the-london-declaration-
on-neglected-tropical-diseases/ (accessed on 29 September 2021).
68. World Health Organization (WHO). Neglected Tropical Diseases: 2020 Preventive Chemotherapy Treatment Coverage
Declines due to COVID-19 Disruptions. 24 September 2021 Departmental News, Geneva, Switzerland. Available on-
line: https://www.who.int/news/item/24-09-2021-neglected-tropical-diseases-2020-preventive-chemotherapy-treatment-
coverage-declines-due-to-covid-19-disruptions (accessed on 28 September 2021).
69. Laing, G.; Vigilato, M.A.N.; Cleaveland, S.; Thumbi, S.M.; Blumberg, L.; Salahuddin, N.; Abdela-Ridder, B.; Harrison, W. One
Health for neglected tropical diseases. Trans R. Soc. Trop. Med. Hyg. 2021, 115, 182–184, Erratum in: Trans. R. Soc. Trop. Med. Hyg.
2021, 115, 940. [CrossRef]
70. Fillâtre, P.; Revest, M.; Tattevin, P. Crimean-Congo hemorrhagic fever: An update. Med. Mal. Infect. 2019, 49, 574–585, Erratum in:
Med. Mal. Infect. 2020, 50, 95–96. [CrossRef]
71. Wright, D.; Kortekaas, J.; Bowden, T.A.; Warimwe, G.M. Rift Valley fever: Biology and epidemiology. J. Gen. Virol. 2019, 100,
1187–1199. [CrossRef]
72. Monath, T.P.; Vasconcelos, P.F. Yellow fever. J. Clin. Virol. 2015, 64, 160–173. [CrossRef]
73. Elbir, H.; Raoult, D.; Drancourt, M. Relapsing fever borreliae in Africa. Am. J. Trop. Med. Hyg. 2013, 89, 288–292. [CrossRef]
74. Cazorla, C.; Socolovschi, C.; Jensenius, M.; Parola, P. Tick-borne diseases: Tick-borne spotted fever rickettsioses in Africa. Infect.
Dis. Clin. N. Am. 2008, 22, 531–544. [CrossRef]
75. Parola, P. Rickettsia felis: From a rare disease in the USA to a common cause of fever in sub-Saharan Africa. Clin. Microbiol. Infect.
2011, 17, 996–1000. [CrossRef]
76. Morelli, S.; Diakou, A.; Di Cesare, A.; Colombo, M.; Traversa, D. Canine and Feline Parasitology: Analogies, Differences, and
Relevance for Human Health. Clin. Microbiol. Rev. 2021, 34, e0026620.
77. AFP/Fox News. Uganda Confirms at Least One Case of Crimean-Congo Fever. 16 August 2013. Available online: https:
//www.foxnews.com/world/uganda-confirms-at-least-one-case-of-crimean-congo-fever (accessed on 25 September 2021).
78. WHO Africa. How Previous Ebola Virus Disease Outbreaks Helped Uganda Respond to COVID-19 Outbreak. 28 August
2021. Available online: https://www.afro.who.int/news/how-previous-ebola-virus-disease-outbreaks-helped-uganda-respond-
covid-19-outbreak (accessed on 28 September 2021).
79. Schmidt-Sane, M.M.; Nielsen, J.O.; Chikombero, M.; Lubowa, D.; Lwanga, M.; Gamusi, J.; Kabanda, R.; Kaawa-Mafigiri, D.
Challenges to Ebola preparedness during an ongoing outbreak: An analysis of borderland livelihoods and trust in Uganda. PLoS
ONE 2020, 15, e0230683. [CrossRef]
80. Mirembe, B.B.; Musewa, A.; Kadobera, D.; Kisaakye, E.; Birungi, D.; Eurien, D.; Nyakarahuka, L.; Balinandi, S.; Tumusiime, A.;
Kyondo, J.; et al. Sporadic outbreaks of crimean-congo haemorrhagic fever in Uganda, July 2018-January 2019. PLoS Negl. Trop.
Dis. 2021, 15, e0009213. [CrossRef]
81. World Health Organisation (WHO). Africa. Government of Uganda Confirms Outbreak of Crimean-Congo Hemorrhagic and Rift
Valley Fevers. 24 January 2018. Available online: https://www.afro.who.int/news/government-uganda-confirms-outbreak-
crimean-congo-hemorrhagic-and-rift-valley-fevers (accessed on 25 September 2021).
82. Kamani, J.; Massetti, L.; Olubade, T.; Balami, J.A.; Samdi, K.M.; Traub, R.J.; Colella, V.; González-Miguel, J. Canine gastrointestinal
parasites as a potential source of zoonotic infections in Nigeria: A nationwide survey. Prev. Vet. Med. 2021, 192, 105385. [CrossRef]
83. Warembourg, C.; Wera, E.; Odoch, T.; Bulu, P.M.; Berger-González, M.; Alvarez, D.; Abakar, M.F.; Maximiano Sousa, F.; Cunha
Silva, L.; Alobo, G.; et al. Comparative Study of Free-Roaming Domestic Dog Management and Roaming Behavior Across Four
Countries: Chad, Guatemala, Indonesia, and Uganda. Front. Vet. Sci. 2021, 8, 617900. [CrossRef] [PubMed]
84. Van Blerk, H. African Lions: Who are Africa’s Rising Middle Class? IPSOS Views #15. February 2018. Available online:
https://www.ipsos.com/en-ug/african-lions-who-are-africas-rising-middle-class (accessed on 27 October 2021).
85. Romig, T.; Deplazes, P.; Jenkins, D.; Giraudoux, P.; Massolo, A.; Craig, P.S.; Wassermann, M.; Takahashi, K.; de la Rue, M. Ecology
and Life Cycle Patterns of Echinococcus Species. Adv. Parasitol. 2017, 95, 213–314. [PubMed]
86. Catalano, S.; Sène, M.; Diouf, N.D.; Fall, C.B.; Borlase, A.; Léger, E.; Bâ, K.; Webster, J.P. Rodents as Natural Hosts of Zoonotic
Schistosoma Species and Hybrids: An Epidemiological and Evolutionary Perspective from West Africa. J. Infect. Dis. 2018, 218,
429–433. [CrossRef] [PubMed]
87. Grace, D.; Songe, M.; Knight-Jones, T. Impact of neglected diseases on animal productivity and public health in Africa. In
Proceedings of the 21st conference of the World Organisation for Animal Health (OIE) Regional Commission for Africa, Rabat,
Morocco, 16–20 February 2015.
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